Autoimmune disorders, rheumatoid arthritis, systemic inflammation, and immune dysregulation
308 artigos
48-week trial shows biological drugs don't outperform standard treatment for patient-reported outcomes in early rheumatoid arthritis.
Updated EULAR recommendations provide evidence-based strategies for managing rheumatoid arthritis using synthetic and biologic medications.
Swedish study finds JAK inhibitors raise keratinocyte cancer risk by 39% compared to TNF inhibitors in RA patients.
Researchers develop breakthrough mouse model for calcium crystal arthritis, opening new paths for treatment development.
A 12-week study shows an app combining exercise, education, and gamification cut disease activity scores by 30% in spinal arthritis patients.
RESIST score identifies high-risk systemic sclerosis patients who may benefit from intensive therapy to prevent early mortality.
New research reveals how blood factors trigger muscle weakness in autoimmune disease and identifies potential therapeutic targets.
Breakthrough study shows CAR T-cell therapy normalizes neutrophil function in lupus, offering new hope for autoimmune treatment.
New study reveals specific immune and microbiome signatures that could predict depression in lupus patients with 85% accuracy.
Scientists use human blood vessel organoids to decode the progression of systemic sclerosis, revealing new therapeutic targets.
Updated EULAR recommendations provide comprehensive management strategies for this complex autoimmune condition affecting multiple organs.
New research reveals progress in lupus pregnancy care while highlighting persistent medication and outcome disparities.
